If you have been spending any time in the pet community, online or in person, you’ve likely heard people talking about the ...

Detailed price information for Tenaya Therapeutics Inc (TNYA-Q) from The Globe and Mail including charting and trades.

Longeveron Inc. (NASDAQ:LGVN) Q4 2025 Earnings Call Transcript March 17, 2026 Longeveron Inc. beats earnings expectations.

By Brad Sorensen, CFA NASDAQ: LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ: LGVN) is a clinical-stage ...

I am excited and honored to join Longeveron at this pivotal moment for the company. The strength of the company's stem cell ...

On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating ...

Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...

The Tacoma Police Department initially investigated the boy’s death as suspicious, but the case was on hold for months ...

A patient fact sheet outlining the differences between heart failure and cardiomyopathy, including subtypes of each condition and diagnostic procedures for both. Cardiomyopathy is a group of heart ...

Credit: Getty Images HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C. Hypertrophic cardiomyopathy (HCM) ...

Shortness of breath, especially during activities that increase the heart rate, can be an early indicator of HCM. Chest pain, which often feels like tightness or pressure, may arise during physical ...

The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Approval of Myqorzo was granted to ...